CDEX (Old)

[Viking65]

CDEX Announces Annual Shareholders Meeting

Last Update: 8:45 AM ET Mar 2, 2006


ROCKVILLE, Md., Mar 02, 2006 (BUSINESS WIRE) -- CDEX, Inc. (CEXI.OB), a developer of innovative technologies for detecting and validating chemical substances, announced today that its 2006 annual meeting of shareholders will be held on Friday, March 17, 2006, at 10:00 a.m. ET at the Doubletree Hotel, 1750 Rockville Pike, Rockville, MD, 20852 / telephone: [phone].
Proxy statements and proxy cards were mailed out on February 17, 2006. Proxies are to be returned to the address shown on the proxy card by no later than 11:59 p.m., March 16, 2006.
About CDEX, Inc.
CDEX, Inc. is a technology development company with a current focus on developing and marketing products using chemical detection and validation technologies. At present, CDEX is devoting its resources to two distinct areas: (i) identification of substances of concern (e.g., explosives and illegal drugs for homeland security); and (ii) validation of substances for anti-counterfeiting, brand protection and quality assurance (e.g., validation of prescription medication and detection of counterfeit or sub-par products for brand protection). ValiMed is one line of CDEX products for the healthcare market. CDEX is headquartered in Rockville, Maryland with its research and development laboratory in Tucson, Arizona. For more information, visit www.cdex-inc.com and www.valimed.com.
Any statements made in this press release which contain information that is not historical are essentially forward-looking. Forward-looking statements can be identified by the use of words such as "expects," "plans," "may," "anticipates," "believes," "should," "intends," "estimates," and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, the ability of the Company to raise capital to finance the development of its chemical detection products, the effectiveness, profitability and the marketability of those products, the ability of the Company to protect its proprietary information, the establishment of an efficient corporate operating structure as the Company grows and, other risks detailed from time-to-time in our filings with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statements.
SOURCE: CDEX, Inc.
For CDEX Brad Wills, 301-767-1919 [e-mail] Copyright Business Wire 2006